Neuwied, Germany

Michael Horstmann

USPTO Granted Patents = 56 

 

 

Average Co-Inventor Count = 2.6

ph-index = 13

Forward Citations = 873(Granted Patents)

Forward Citations (Not Self Cited) = 855(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Andernach, DE (2010)
  • Neuwied, DE (1989 - 2022)
  • Neuweid, DE (2023)

Company Filing History:


Years Active: 1989-2023

Loading Chart...
Loading Chart...
Loading Chart...
56 patents (USPTO):Explore Patents

Title: Michael Horstmann: Innovation in Transdermal Therapeutics and Medical Technology

Introduction:

Michael Horstmann, an accomplished inventor based in Neuwied, Germany, has made significant contributions to the field of transdermal therapeutics and medical technology. With a remarkable portfolio of 56 patents, Horstmann's expertise lies in developing transdermal systems and adhesive bandages that efficiently and effectively administer pharmaceutical active ingredients. This article sheds light on Horstmann's latest patents, career highlights, notable collaborations, and his overall contribution to the field of medical innovation.

Latest Patents:

Among Horstmann's recent patents, two notable inventions stand out. The first is a groundbreaking transdermal therapeutic system for administering water-soluble peptides and polypeptides. This system enables the controlled release of pharmaceutical active ingredients from an aqueous phase via an occlusive back layer and a dispensing device that maintains a stationary solid phase and a liquid phase containing the active ingredient in an aqueous solution.

The second patent focuses on water-vapor-permeable adhesive bandages. These bandages incorporate a water-vapor permeable back layer and an adhesive layer containing hydrophilic particles. The adhesive layer is formulated with a styrene block copolymer, an ester resin of colophony, and potentially, relevant anti-virus substances. This innovative design allows for improved breathability and enhanced absorption in wound care.

Career Highlights:

Throughout his career, Michael Horstmann has worked diligently to advance transdermal therapeutic systems and adhesive bandages. His contributions have immensely impacted the medical field, particularly in drug delivery methods and wound care solutions. Horstmann's patent portfolio serves as a testament to his dedication and skill in developing novel therapies that improve patient outcomes and comfort.

Collaborations:

Horstmann has collaborated with various renowned companies in the medical and pharmaceutical sector. One notable affiliation is with Lohmann Therapie-Systeme AG (LTS), a global leader in transdermal therapeutic systems. His association with LTS showcases his commitment to developing innovative solutions that align with industry demands and standards. Additionally, Horstmann has also collaborated with other accomplished professionals, including Wolfgang Laux and Mohammad Sameti, further highlighting his ability to work synergistically and foster knowledge-sharing within the field.

Conclusion:

Michael Horstmann's passion for innovation and commitment to advancing transdermal therapeutics and medical technology have resulted in an impressive portfolio of 56 patents. His expertise in developing transdermal systems and adhesive bandages showcases his ability to create solutions that offer improved drug delivery and wound care options for patients. As medical technology continues to evolve, Horstmann's contributions remain invaluable, paving the way for further advancements and improved patient care in the future.

Note: The information provided in this article is based on the given data about Michael Horstmann.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…